| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d269c8e41f178194d858c230c9f85e3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-10 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-14 |
| filingDate |
1992-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad1b364e22047d75e7072123e51f9e75 |
| publicationDate |
1993-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9301162-A1 |
| titleOfInvention |
Process for preparing sertraline |
| abstract |
The invention provides the substantially geometrically pure cis-stereoisomeric form of a compound of formula (I) and the substantially geometrically and optically pure cis-stereoisomeric form of a compound of formula (II) wherein R1 is H or C¿1?-C4 alkyl, together with processes for their preparation. The compounds are intermediates for the preparation of the antidepressant agent known as sertraline. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6262308-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0947499-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0947499-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2777000-A1 |
| priorityDate |
1991-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |